The fight against Tuberculosis (TB), a contagious disease primarily affecting the lungs, continues to evolve with advancements in diagnostic techniques. This article reviews the latest developments in TB detection, focusing on their efficacy and potential impact on patient outcomes.
Introduced in 2010, the GeneXpert MTB/RIF test revolutionized TB diagnostics. This molecular test identifies Mycobacterium tuberculosis and resistance to rifampicin in less than two hours. Its high sensitivity and specificity, even in smear-negative samples, make it a valuable tool in TB control, particularly in HIV co-infection and paediatric cases.
Line Probe Assays (LPAs) are another significant advancement. These molecular techniques detect specific genetic mutations associated with drug resistance. WHO has endorsed LPAs for the detection of multidrug-resistant TB (MDR-TB) due to their rapid turnaround time and high accuracy.
Next-Generation Sequencing (NGS) is a promising method for TB diagnosis. It allows comprehensive analysis of the entire Mycobacterium tuberculosis genome, providing information about drug resistance and genetic diversity. Although still in research phases, NGS has the potential to become a 'one-stop-shop' for TB diagnosis and drug susceptibility testing.
Advancements in imaging techniques, like the introduction of digital radiography and computer-aided detection, have improved the accuracy of TB diagnosis. These technologies offer better image quality and interpretation, aiding early detection and treatment initiation.
While smear microscopy and culture remain the backbone of TB diagnosis, these advancements offer faster, more accurate detection. They also provide insights into drug resistance, crucial for improving treatment strategies. As we continue to strive for TB elimination, embracing these innovative diagnostic approaches will be instrumental in achieving this goal.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation